Loading
GT
GlobeStar Therapeutics Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Blankenship Alex K, was filed 25 Aug 2020.
GlobeStar Therapeutics Corp: what insiders have been doing
GlobeStar Therapeutics Corp belongs to the Health Care sector. Filings by its managers are published through SEC (Form 4). GlobeStar Therapeutics Corp has had no insider filing for more than a year; the last one goes back to 4 April 2023.
Over the whole record (from 2017), the tally stands at 16 purchases and no sales.
In the same sector, recent insider purchases at Xenon Pharmaceuticals Inc. and Vivos Inc also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
29
Thresholds
n/a
Buy Volume
€4B
16 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +478.9%Entry US$0.01 · Close at T+365 US$0.03
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2023FY ended September 2023 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$66
Gross profit-US$2.1k-3147% margin
EBITDA-US$1.9M-2814615% margin
Net income-US$1.9M0.0% margin
Valuation
Beta1.12
Balance sheet & cash
Total debtUS$366k
Free Cash Flow-US$205.8k
Last declaration on 4 April 2023
Declarations29 total
7,042,253 shares@ US$0.0071100.0% of flowCommon stockSEC:0001161697-23-000225:0
70,422,535 shares@ €0.006590.9% of flowCommon stockSEC:0001161697-23-000221:0
5,000,000 shares@ US$0.0001100.0% of flowCommon stockSEC:0001677687-20-000001:3
Canonical exit: 12 Nov 2020 (T+90)
500,000 shares0Common stockSEC:0001677687-20-000001:0
Canonical exit: 16 Jul 2017 (T+90)
2,000,000 shares@ US$2,000.00Common stockSEC:0001677687-20-000001:1
Canonical exit: 17 Oct 2017 (T+90)
3,500,000 shares0Common stockSEC:0001677687-20-000001:2
Canonical exit: 6 Mar 2019 (T+90)
1,000,000 shares@ US$1,000.00Series E preferred stockSEC:0001677687-20-000001:4
Canonical exit: 9 Nov 2016 (T+90)
7,447,200 shares0Common SharesSEC:0001062993-20-001202:3
6,000,000 shares0Common SharesSEC:0001062993-20-001202:4
2,000,000 shares0Common SharesSEC:0001062993-20-001202:5
50,000 shares0Common SharesSEC:0001062993-20-001202:6
250,000 shares0Common SharesSEC:0001062993-20-001202:7
1,650,000 shares0Common SharesSEC:0001062993-20-001202:8
2,148,604 shares0Common SharesSEC:0001062993-20-001202:9
170,000 shares0Common SharesSEC:0001062993-20-001202:10
2,750,000 shares0Common SharesSEC:0001062993-20-001202:0
2,282,400 shares0Common SharesSEC:0001062993-20-001202:1
6,927,500 shares0Common SharesSEC:0001062993-20-001202:2
1,750,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:0
Canonical exit: 11 Nov 2019 (T+90)
500,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:1
Canonical exit: 12 Nov 2019 (T+90)
750,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:2
Canonical exit: 12 Nov 2019 (T+90)
77,188 shares@ US$0.02Common SharesSEC:0001567619-19-017140:3
Canonical exit: 12 Nov 2019 (T+90)
2,500,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:4
Canonical exit: 11 Nov 2019 (T+90)
250,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:5
Canonical exit: 12 Nov 2019 (T+90)
4,000,000 shares@ US$0.02Common SharesSEC:0001567619-19-017140:6
Canonical exit: 11 Nov 2019 (T+90)
25 of 29 declarations
About GlobeStar Therapeutics Corp
GlobeStar Therapeutics Corp is a company focused on developing innovative therapies for the treatment of chronic diseases. It is listed on the XNAS market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
